RIL
TSHA icon

Rothschild Investment LLC’s Taysha Gene Therapies TSHA Stock Holding History

Rothschild Investment LLC’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16K Hold
170
– – ﹤0.01% 2997
2026
Q1 		$760 Buy
170
+100
+143% +$465 ﹤0.01% 2982
2025
Q4 		$385 Buy
+70
New +$340 ﹤0.01% 2992
2025
Q3 		– Sell
-105
Closed -$243 – 3249
2025
Q2 		$243 Buy
+105
New +$228 ﹤0.01% 2902
2025
Q1 		– Sell
-130
Closed -$225 – 3092
2024
Q4 		$225 Buy
+130
New +$270 ﹤0.01% 2769

Other funds holding TSHA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
AWM
Affinity Wealth Management Wilmington, Delaware $776M AUM 43.59% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Rothschild Investment LLC's TSHA Position: Q2 2026 in Review

Rothschild Investment LLC held its Taysha Gene Therapies (TSHA) position steady in Q2 2026 at 170 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #2997.

Rothschild Investment LLC first reported a position in TSHA in Q4 2024 and has held it in 5 quarters since. 61 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Rothschild Investment LLC held 170 shares of Taysha Gene Therapies worth $1.16K as of Q2 2026.
  • Rothschild Investment LLC left its Taysha Gene Therapies share count unchanged in Q2 2026.
  • Taysha Gene Therapies made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2997 holding.
  • Rothschild Investment LLC first reported a position in Taysha Gene Therapies in Q4 2024 and has held it in 5 quarters since.
  • 61 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.